Lipidstoffwechsel aktuell: statininduzierte Myopathien.

LL Teichmann, M Fleck - Zeitschrift für Rheumatologie, 2010 - search.ebscohost.com
English Cardiovascular diseases are the most common causes of death in Germany and the
prevalence is increased in patients with inflammatory rheumatic diseases. Statins are often …

Statins and muscular side-effects

C Brosteaux, J Ruiz, T Buclin, T Kuntzer… - Revue Medicale …, 2010 - europepmc.org
Statins are effective in the treatment of hypercholesterolemia for primary and secondary
prevention of cardiovascular disease. While most side effects of statins are mild and …

Muscle problems due to statins: underestimated

SP Janssen, YM Smulders, VE Gerdes… - Nederlands Tijdschrift …, 2010 - europepmc.org
Statin-associated muscle problems are more common than the 1-5% prevalence reported in
large clinical trials. Observational studies show a prevalence of about 10%. Muscle …

Statin-Induced Myopathy and its Management.

C Buettner, MA Kriegel, RE Wells… - Current Medical …, 2010 - search.ebscohost.com
The article discusses a study on statin-induced myopathy and its management. There are
several factors that increase the risk of statin-induced myopathy, and an underlying …

Statin-induced Myopathy: atherosclerotic cardiovascular disease

AJ Dalby - SA Heart, 2015 - journals.co.za
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide.
HMGCoA reductase inhibitors or" statins" reduce low density lipoprotein cholesterol and …

Muscle-and skeletal-related side-effects of statins: tip of the iceberg?

J Auer, H Sinzinger, B Franklin… - European Journal of …, 2016 - academic.oup.com
The clinical spectrum of muscle-and skeletal-related side-effects of statins includes varied
myalgias and weakness, an asymptomatic increase in the concentration of creatine kinase …

Statin-related muscle complaints: an underestimated risk

A Corsini - Cardiovascular drugs and therapy, 2005 - search.proquest.com
Controlled clinical studies and clinical experience over many years have proven that
virtually all patients at high cardiovascular risk benefit from lipid-lowering therapy with …

Statin myopathy: A problem looking for a solution

KR Feingold - Atherosclerosis, 2015 - atherosclerosis-journal.com
Statins are one of the most commonly used classes of drugs because they have been shown
to significantly reduce cardiovascular disease in both primary and secondary prevention …

Safe use of statins: focus on muscle toxicity

V Kolovou, H Bilianou, G Kolovou - Clinical Lipidology, 2016 - Taylor & Francis
Muscle toxicity can be classified as myopathy, myalgia, myositis or rhabdomyolysis (RM).
RM can occur in patients with muscular dystrophy, alcoholic myopathy, peripheral artery …

Statin-induced myopathies

M Tomaszewski, KM Stępień, J Tomaszewska… - Pharmacological …, 2011 - Springer
Statins are considered to be safe, well tolerated and the most efficient drugs for the treatment
of hypercholesterolemia, one of the main risk factor for atherosclerosis, and therefore they …